Parallel Advisors, LLC Red Hill Biopharma Ltd. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$2.31 - $5.85 $219 - $555	-95 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$4.55 - $10.36 $432 - $984	95 New	95 $0
Q4 2020 Feb 02, 2021	SELL	$7.81 - $10.39 $1,374 - $1,828	-176 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$6.34 - $10.83 $1,115 - $1,906	176 New	176 $2,000
Q4 2017 Feb 13, 2018	SELL	$4.58 - $10.81 $6,412 - $15,134	-1,400 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$8.25 - $10.81 $11,550 - $15,134	1,400	1,400 $7,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $452M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.